Associate Professor of Oncology, Johns Hopkins University School of Medicine; Member, Tumor Immunology Research Program, Member, Breast Cancer Research Program
Oncology
Dr. Leisha A. Emens, MD
|
|
Give Review
Leisha Emens practices Oncology. She studied medicine at University of Texas Southwestern Medical School. She received awards:"America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "America's Top Doctors for Cancer", "Top Doctors:Baltimore Area" and "Top Doctors:Washington-Baltimore". Leisha Emens is a published physician. She published 60 publications, including: 'The myc intron-binding polypeptide associates with RFX1 in vivo and binds to the major histocompatibility complex class II promoter region, to the hepatitis B virus en...' She accepts all Medicare patients.
Publications
- The immune microenvironment of Breast ductal carcinoma in situ.
- Targeting the programmed cell death-1 pathway in Breast and ovarian cancer.
- Chemotherapy-A Viable Partner for Cancer Immunotherapy?
- PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic Breast carcinomas.
- A Feasibility Study of Cyclophosphamide, Trastuzumab, and an Allogeneic GM-CSF-Secreting Breast Tumor Vaccine for HER2+ Metastatic Breast Cancer.
- A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway.
- Metastatic triple-negative Breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary Breast tumors: a pilot study.
- HER2-directed therapy for metastatic Breast cancer.
- Chemoimmunotherapy: reengineering tumor immunity.
- A short-term biomarker modulation study of simvastatin in women at increased risk of a new Breast cancer.
- Changes in Breast Density and Circulating Estrogens in Postmenopausal Women Receiving Adjuvant Anastrozole.
- GM-CSF-secreting vaccines for solid tumors: moving forward.
- Chemoimmunotherapy.
- Pathologic complete response to preoperative sequential doxorubicin/cyclophosphamide and single-agent taxane with or without trastuzumab in stage II/III HER2-positive ...
- Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice.
- Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting Breast tumor vaccine: a che...
- African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative Breast cancer suffer worse outcomes compared with white women.
- Feasibility trial of partial Breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage Breast cancer.
- Postoperative endocrine therapy for invasive Breast cancer.
- Antibody association with HER-2/neu-targeted vaccine enhances CD8 T cell responses in mice through Fc-mediated activation of DCs.
- Chemotherapy and tumor immunity: an unexpected collaboration.
- A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immune-based mechanism.
- Cancer vaccines: toward the next revolution in Cancer therapy.
- Roadmap to a better therapeutic tumor vaccine.
- OX40 costimulation synergizes with GM-CSF whole-cell vaccination to overcome established CD8+ T cell tolerance to an endogenous tumor antigen.
- Leveraging the activity of tumor vaccines with cytotoxic chemotherapy.
- Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response.
- Trastuzumab: targeted therapy for the management of HER-2/neu-overexpressing metastatic Breast cancer.
- Cancer vaccines in combination with multimodality therapy.
- A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting Breast cancer vaccine given in a specifically timed sequence with immuno...
- Survivin' Cancer.
- Toward a Breast cancer vaccine: work in progress.
- HER-2/neu-specific monoclonal antibodies collaborate with HER-2/neu-targeted granulocyte macrophage colony-stimulating factor secreting whole cell vaccination to augme...
- Cancer vaccines: an old idea comes of age.
- The follow-up of Breast cancer.
- A new twist on autologous Cancer vaccines.
- Adjuvant hormonal therapy for premenopausal women with Breast cancer.
- Regression of splenic lymphoma after treatment of hepatitis C virus infection.
- To live or not to live: that depends on GAGE?
- Cytokine gene-modified cell-based Cancer vaccines.
- Introducing the clinical trials monitor: a new section of the journal for immunotherapy of Cancer.
- The multikinase inhibitor sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE₂ in murine macrophages.
- Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic Breast cancer.
- Hepatocyte nuclear factor 1 alpha is expressed in a hamster insulinoma line and transactivates the rat insulin I gene.
- A phase I toxicity and feasibility trial of sequential dose-dense induction chemotherapy with doxorubicin, paclitaxel, and 5-fluorouracil followed by high dose consoli...
- Cost-effective manufacture of an allogeneic GM-CSF-secreting Breast tumor vaccine in an academic cGMP facility.
- GV-1001, an injectable telomerase peptide vaccine for the treatment of solid Cancers.
- Towards a therapeutic Breast cancer vaccine: the next steps.
- Cancer vaccines: on the threshold of success.
- GM-CSF-secreting vaccines for solid tumors.
- Consensus report of the national Cancer institute clinical trials planning meeting on pancreas Cancer treatment.
- New findings about endocrine therapy for Breast cancer.
- Breast cancer vaccines: maximizing cancer treatment by tapping into host immunity.
- Augmenting the potency of Breast cancer vaccines: combined modality immunotherapy.
- Humoral and cellular immune responses: independent forces or collaborators in the fight against Cancer?
- Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines i...
- Chemotherapy: friend or foe to Cancer vaccines?
- The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.
- The myc intron-binding polypeptide associates with RFX1 in vivo and binds to the major histocompatibility complex class II promoter region, to the hepatitis B virus en...
Schools
Baylor University
University Tx At Sw Affil Hosps
Johns Hopkins
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
Conditions Treated
- Breast Cancer
- Colorectal Cancer
- Liver Cancer
- Lung Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- America's Top Doctors for Cancer
- Top Doctors:Baltimore Area
- Top Doctors:Washington-Baltimore
Education
-
Johns Hopkins University -
University of Texas Southwestern Medical School -
Baylor College of Medicine
Hospital
-
Johns Hopkins Hospital
Drug Facts
| NPI NUMBER | 1003845132 | |
| NPPES Provider LastName | EMENS | |
| NPPES Provider FirstName | LEISHA | |
| NPPES Provider ZIPCode | 212870005 | |
| NPPES Provider State | MD | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 33.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1003845132 |
| Last Name Of The Provider | EMENS |
| First Name Of The Provider | LEISHA |
| View All |
Similar Doctors
|
|
Dr. Katherine H. Tkaczuk, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carole B. Miller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Danijela Jelovac, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mian K. Khalid, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hetty E. Carraway, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mei Tang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ting Bao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Meyer R. Heyman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles A. Padgett, MD |
|
|
Dr. David A. Riseberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arvind Y. Vemula, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ashraf Z. Badros, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laurence A. Doyle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fang Yin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rosalyn A. Juergens, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pamela B. Allen, MD |
|
|
Dr. Andrea C. Baines, MD |
|
|
Dr. Samuel Zygler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip H. Imus, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gabrielle T. Prince, MD
This Doctor is OpenDoctor Recommended.
|